CD4 and neoplasm: This study considers the possibility that CXCR4-tropic HIV could inhibit tumor-promoting macrophages and the potential for CXCR4-tropic HIV to induce apoptosis in breast cells independently of CD4 interaction, suggesting a unique mechanism by which these HIV variants might reduce BC risk.